A major breakthrough in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently lost in various forms of tumors, resulting uncontrolled https://businessbookmark.com/story7562079/nanobodies-reactivate-tumor-suppressor-p53-new-promising-pathway-for-malignant-management